Grant: Planning Grants - Priority Announcement: Nutrition, Metabolism & Diabetes
University of British Columbia
$23,756.00
The Role of Gut Bacteria in the Pathogenesis and Prevention of Kidney Stone Disease
FY 2010-11
Summary
The purpose of this meeting grant is to facilitate an international cross-disciplinary collaboration of varied physicians and basic scientists with the goal of improving the treatment for patients suffering from kidney stones. This collaboration is needed because no definitive therapy exists to consistently prevent kidney stones which affects 33 million North Americans and cost the medical system billions of dollars per year. The goal of our research is to alter gut bacteria to change dietary absorption of kidney stone elements in patients suffering from recurrent kidney stones. There is evidence that patients with kidney stones have an imbalance in their gut bacteria. Identifying differences in gut bacteria of patients with and without kidney stones will help direct therapy. Gut bacteria (known as the "microbiome") are known to alter what is absorbed from food and transported across the gastrointestinal tract into blood. Once altered foodstuffs are filtered by the kidney, compounds such as calcium and oxalate may form kidney stones. We will utilize DNA identification techniques that can identify specific gut bacterial species (metagenomics) that traditional microbiology culturing techniques have been unable to identify. Traditional microbiology culturing techniques are only capable of identifying 1% of the gut bacteria.
Gut bacteria have been shown to play a critical role in diseases such as inflammatory bowel disease and obesity. By identifying specific gut bacteria more commonly found in normal controls, we plan to change the gut bacteria in kidney stone patients to alter the gut metabolism of compounds that contribute to kidney stones. This technique of "stool transplantation" previously has been shown to alter obesity in experimental mice, and has recently been used clinically in diseases such as C. difficile colitis. This novel approach of directed stool transplantation will potentially provide consistent relief for patients with recurrent kidney stones.
Department
Program
Planning Grants - Priority Announcement: Nutrition, Metabolism & Diabetes
Recipient
Location
British Columbia, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
228392
Name
Chew Ben H
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Planning Grants
Projecttitle
The Role of Gut Bacteria in the Pathogenesis and Prevention of Kidney Stone Disease
Programtype2
Miscellaneous Programs
Orgnameinp2
University of British Columbia
Cihramount2
$23,756
Cihrequipment2
$0
Programname2
Planning Grants - Priority Announcement: Nutrition, Metabolism & Diabetes
Keyworddelim
Bacteriotherapy; Kidney Stones; Metagenomics; Microbiome
Abstract
The purpose of this meeting grant is to facilitate an international cross-disciplinary collaboration of varied physicians and basic scientists with the goal of improving the treatment for patients suffering from kidney stones. This collaboration is needed because no definitive therapy exists to consistently prevent kidney stones which affects 33 million North Americans and cost the medical system billions of dollars per year. The goal of our research is to alter gut bacteria to change dietary absorption of kidney stone elements in patients suffering from recurrent kidney stones. There is evidence that patients with kidney stones have an imbalance in their gut bacteria. Identifying differences in gut bacteria of patients with and without kidney stones will help direct therapy. Gut bacteria (known as the "microbiome") are known to alter what is absorbed from food and transported across the gastrointestinal tract into blood. Once altered foodstuffs are filtered by the kidney, compounds such as calcium and oxalate may form kidney stones. We will utilize DNA identification techniques that can identify specific gut bacterial species (metagenomics) that traditional microbiology culturing techniques have been unable to identify. Traditional microbiology culturing techniques are only capable of identifying 1% of the gut bacteria.
Gut bacteria have been shown to play a critical role in diseases such as inflammatory bowel disease and obesity. By identifying specific gut bacteria more commonly found in normal controls, we plan to change the gut bacteria in kidney stone patients to alter the gut metabolism of compounds that contribute to kidney stones. This technique of "stool transplantation" previously has been shown to alter obesity in experimental mice, and has recently been used clinically in diseases such as C. difficile colitis. This novel approach of directed stool transplantation will potentially provide consistent relief for patients with recurrent kidney stones.
Competitiondate
201102
Approvedterm2
1 yr 0 mth
Pinamesdelim
Chew, Ben H
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $23,756~ $0~